Related Experiment Videos
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer
1Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.
Medical Oncology (Northwood, London, England)
|September 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
European journal of cancer (Oxford, England : 1990)·2013
Does informed adjuvant placebo chemotherapy for breast-cancer elicit immune changes.
Oncology reports·2011
Blood lymphocyte subsets in operable breast-cancer - relation to extent of tumor disease and prognosis.
International journal of oncology·2011
Different dose regimens of the mouse monoclonal-antibody 17-1a for therapy of patients with metastatic colorectal-carcinoma.
International journal of oncology·2011
Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
Anticancer research·2010
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Acta oncologica (Stockholm, Sweden)·2008
Curcumin in ovarian cancer: mechanistic insights and translational potential.
Medical oncology (Northwood, London, England)·2026
Silencing the genome: role of HUSH complex in retrotransposon regulation and cancer development.
Medical oncology (Northwood, London, England)·2026
Nutritional inflammatory hematological risk index predicts clinical outcomes in patients with advanced NSCLC receiving immunotherapy.
Medical oncology (Northwood, London, England)·2026
Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression.
Medical oncology (Northwood, London, England)·2026
A20 promotes OPN ubiquitination and degradation to inhibit cell growth and invasion in human hepatocellular carcinoma.
Medical oncology (Northwood, London, England)·2026
GLIS3 promotes the malignant biological behavior of gastric cancer cells by transcriptionally regulating PNPO to influence autophagy.
Medical oncology (Northwood, London, England)·2026
Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.
Frontiers in medicine·2026
Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.
Frontiers in medical technology·2026